MoonLake Immunotherapeutics
- Market cap
- 916.60M
- P/E (TTM)i
- -2.80
- P/Bi
- 2.14
- EPSi
- -3.53
- Div yieldi
- 0.00%
- 52W posi
- 14%
Anonymous reader poll. Unscientific, not investment advice.
MoonLake Immunotherapeutics ended the session at 10.77, down 1.64%. At current prices, the business is worth about 916.60M, the #3305 most valuable US-listed company we track. Wall Street's 7-analyst consensus lands on Buy, with a price target averaging 34.50 (+220% from here). The shares sit 14% of the way up their 52-week range of 8.80 to 23.29.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Valuation sits at the 53% percentile of its own 5-year range.
- Price momentum averages -13.9% across the trailing 3-month/1-year windows.
- Analyst consensus across 7 analysts is Buy.
- Recent price momentum is -13.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 10.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 10.95
- Open
- 10.81
- Day range
- 10.71 - 11.29
- Avg price
- 10.94
- Volume
- 1.40M
- Turnover
- 15.27M
- Turnover ratei
- 2.52%
- Volume ratioi
- 0.65
- Amplitudei
- 5.30%
- 52-week rangei
- 8.80 - 23.29
Valuation
- P/Ei
- -3.05
- P/E (TTM)i
- -2.80
- P/Bi
- 2.14
- EPSi
- -3.53
- Book value / shi
- 5.03
- Net profit
- -300.43M
- Net assets
- 428.17M
Share structure
- Market cap
- 916.60M
- Float capi
- 597.39M
- Shares out
- 85.11M
- Float sharesi
- 55.47M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-10-20
53.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-24.86M net over the window
Short interest
- Shares short
- 8.95M
- % of floati
- 10.51%
- Days to coveri
- 6.07
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of MoonLake Immunotherapeutics (MLTX)?
MoonLake Immunotherapeutics last traded at 10.77. The quote on this page refreshes every few seconds while US markets are open.
What is MoonLake Immunotherapeutics's market cap?
About 916.60M.
What is the P/E ratio of MoonLake Immunotherapeutics?
The trailing twelve-month P/E is -2.80. The Valuation tab shows it against the stock's own five-year range.
Does MoonLake Immunotherapeutics pay a dividend?
MoonLake Immunotherapeutics does not currently pay a regular dividend.
Is MoonLake Immunotherapeutics a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 34.50, which implies 220.3% upside from the current price. This is not investment advice.
Quote time 2026-10-08 08:19:37 · For reference only, not investment advice and not tailored to your situation.